Drug Delivery Products

Gains will be driven by dosages that better treat autoimmune, cancer, cardiovascular, neurological, viral, and other debilitating disorders, and by devices that are safer, prevent infection and are easier to use.

US demand to reach $251 billion in 2019

US demand for drug delivery products is forecast to grow 6.1 percent annually to $251 billion in 2019. Specialized dosage formulations that improve therapies for autoimmune, cancer, cardiovascular, neurological, viral, and other debilitating disorders will lead gains. Included in this group are human and humanized monoclonal antibodies, polymer-encapsulated medicines, and brachytherapy seeds. Among drug delivery devices, pen injectors and retractable prefillable syringes will record the fastest revenue growth based on safety, infection prevention, and ease-of-use advantages. Demand for oral drug delivery products will benefit from bioavailability and reduced dosing advantages, while controlled-release formulations will continue to dominate revenues. On the downside, patent expirations and generic competition will soften overall growth potential for this product segment.

Prefillable syringes to lead strong gains in parenteral drug delivery

US demand for parenteral drug delivery products is projected to post double-digit gains through 2019. Advances in monoclonal antibodies and polymer-encapsulated medicines will underlie growth. The use of new and existing therapies based on human and humanized monoclonal antibodies will improve the effectiveness of remedies against various forms of cancer and other long-term disorders, such as allergy-linked asthma, Crohn’s disease, rheumatoid and psoriatic arthritis, and wet age-related macular degeneration. Enhanced bioavailability and reduced toxicity advantages will boost applications for polymer-enhanced medicines in the treatment of conditions such as cancer complications, hepatitis B and C, and multiple sclerosis. Among parenteral delivery devices, prefillable syringes will account for the largest and fastest expanding demand over the long term. Improvements in safety features such as automatic needle retraction, along with overall infection prevention and response time advantages, will benefit growth. Prefillable syringes will also broaden self-use applications based on advances in pen injectors and related apparatus.

Mixed outlook for inhalers

Demand for other drug delivery products is expected to surpass $34 billion in 2019. Dry powder and metered dose inhalers will account for more than three-fourths of revenues, reflecting upward trends in prevalence of asthma and chronic obstructive pulmonary disease (COPD). On the downside, growth prospects for inhalers will weaken gradually as patent expirations make several widely used respiratory therapies -- such as ADVAIR, SPIRIVA and SYMBICORT -- available to low cost generic competition. Limited indications and competition from alternative therapies will hold down demand for transdermal drug delivery products. Within this product group, overactive bladder and estrogen replacement therapies will post the fastest revenue growth. Contraceptive inserts will draw the largest and fastest expanding revenues among implantable drug delivery products based on convenience and effectiveness advantages in birth control applications. Brachytherapy implants will also fare well in the marketplace, spurred by increasing use in cervical, prostate, breast, and skin cancer treatment. Im-plantable drug pumps will see moderate growth in demand as improvements in device safety broadens applications in the delivery of pain control and ophthalmic medication. Recent introductions and a rise in heart conditions will foster growth in the market for drug-eluting stents.

Study coverage

This study analyzes the $187 billion US drug delivery system industry. It presents historical demand data (2004, 2009 and 2014) and forecasts (2019 and 2024) by product (e.g., oral, parenteral, inhalation, transdermal, implantable) and application (e.g., central nervous system, hormones, respiratory, anti-infective, cardiovascular, gastrointestinal, nutritional). The study also considers market environment factors, details industry structure, evaluates company market share, and profiles 30 industry players, including Gilead Sciences, Roche, and Johnson & Johnson.

Back to Top

Purchase Drug Delivery Products by the Page or Section

Add Selections to Cart

  1. Drug Delivery Products

    $5,300.00

  2. INTRODUCTION: DRUG DELIVERY PRODUCTS TO 2019

    $0.00

  3. Methodology & Sources of Information

    $0.00

  4. EXECUTIVE SUMMARY: DRUG DELIVERY PRODUCTS TO 2019

    $155.00

  5. Overview

    $35.00

  6. DRUG DELIVERY PRODUCT DEMAND BY TYPE (billion dollars) 2009 - 2024

    $60.00

  7. DRUG DELIVERY PRODUCT DEMAND BY THERAPEUTIC CLASS (billion dollars) 2009 - 2024

    $60.00

  8. MARKET ENVIRONMENT: DRUG DELIVERY PRODUCTS TO 2019

    $2,005.00

  9. General

    $35.00

  10. Economic Factors (1 of 4)

    $35.00

  11. Economic Factors (2 of 4)

    $35.00

  12. Economic Factors (3 of 4)

    $35.00

  13. Economic Factors (4 of 4)

    $35.00

  14. MACROECONOMIC INDICATORS 2004 - 2024

    $60.00

  15. Demographic Patterns (1 of 2)

    $35.00

  16. Demographic Patterns (2 of 2)

    $35.00

  17. RESIDENT POPULATION BY AGE GROUP (million persons) 2004 - 2024

    $60.00

  18. Health Insurance Reforms (1 of 3)

    $35.00

  19. Health Insurance Reforms (2 of 3)

    $35.00

  20. Health Insurance Reforms (3 of 3)

    $35.00

  21. HEALTH INSURANCE COVERAGE OF THE US POPULATION (million enrollees) 2004 - 2014

    $60.00

  22. Acute Medical Conditions

    $35.00

  23. ACUTE CONDITIONS BY TYPE (million) 2004 - 2024

    $60.00

  24. Chronic Medical Conditions (1 of 2)

    $35.00

  25. Chronic Medical Conditions (2 of 2)

    $35.00

  26. CHRONIC CONDITIONS BY TYPE (million) 2004 - 2024

    $60.00

  27. National Health Expenditures: Spending Categories (1 of 3)

    $35.00

  28. National Health Expenditures: Spending Categories (2 of 3)

    $35.00

  29. National Health Expenditures: Spending Categories (3 of 3)

    $35.00

  30. NATIONAL HEALTH EXPENDITURES BY SPENDING CATEGORY (billion dollars) 2004 - 2024

    $60.00

  31. National Health Expenditures: Funding Sources (1 of 2)

    $35.00

  32. National Health Expenditures: Funding Sources (2 of 2)

    $35.00

  33. NATIONAL HEALTH EXPENDITURES BY FUNDING SOURCE (billion dollars) 2004 - 2024

    $60.00

  34. Medical Providers (1 of 3)

    $35.00

  35. Medical Providers (2 of 3)

    $35.00

  36. Medical Providers (3 of 3)

    $35.00

  37. MEDICAL PROVIDERS BY TYPE 2004 - 2024

    $60.00

  38. Patient Activity (1 of 2)

    $35.00

  39. Patient Activity (2 of 2)

    $35.00

  40. PATIENT ACTIVITY BY TYPE 2004 - 2024

    $60.00

  41. Pharmaceutical Industry: Overview

    $35.00

  42. Pharmaceutical Industry: Regulation (1 of 2)

    $35.00

  43. Pharmaceutical Industry: Regulation (2 of 2)

    $35.00

  44. Pharmaceutical Industry: Research & Development

    $35.00

  45. Pharmaceutical Product Demand: Therapeutic Groups (1 of 2)

    $35.00

  46. Pharmaceutical Product Demand: Therapeutic Groups (2 of 2)

    $35.00

  47. PHARMACEUTICAL DEMAND BY THERAPEUTIC CLASS (billion dollars) 2004 - 2024

    $60.00

  48. Pharmaceutical Product Demand: Dosage Formulations (1 of 2)

    $35.00

  49. Pharmaceutical Product Demand: Dosage Formulations (2 of 2)

    $35.00

  50. PHARMACEUTICAL DEMAND BY DOSAGE FORMULATION (billion dollars) 2004 - 2024

    $60.00

  51. Pharmaceutical Product Demand: Regulatory Classes

    $35.00

  52. PHARMACEUTICAL DEMAND BY REGULATORY CLASSIFICATION (billion dollars) 2004 - 2024

    $60.00

  53. Pharmaceutical Product Demand: Commercial Status (1 of 3)

    $35.00

  54. Pharmaceutical Product Demand: Commercial Status (2 of 3)

    $35.00

  55. Pharmaceutical Product Demand: Commercial Status (3 of 3)

    $35.00

  56. PHARMACEUTICAL DEMAND BY PATENT STATUS (billion dollars) 2004 - 2024

    $60.00

  57. DRUG DELIVERY PRODUCT OVERVIEW: DRUG DELIVERY PRODUCTS TO 2019

    $485.00

  58. Overview

    $35.00

  59. Types of Drug Delivery Products (1 of 2)

    $35.00

  60. Types of Drug Delivery Products (2 of 2)

    $35.00

  61. DRUG DELIVERY PRODUCT DEMAND BY TYPE (billion dollars) 2004 - 2024

    $60.00

  62. Drug Delivery Products: Historical Market Trends (1 of 2)

    $35.00

  63. Drug Delivery Products: Historical Market Trends (2 of 2)

    $35.00

  64. DRUG DELIVERY PRODUCT DEMAND PATTERNS, 2004 - 2014

    $60.00

  65. US Trade in Drug Delivery Products

    $35.00

  66. US TRADE IN DRUG DELIVERY PRODUCTS (billion dollars) 2004 - 2024

    $60.00

  67. International Markets for Drug Delivery Products

    $35.00

  68. WORLD DRUG DELIVERY PRODUCT DEMAND BY REGION (billion dollars) 2004 - 2024

    $60.00

  69. ORAL DRUG DELIVERY PRODUCTS: DRUG DELIVERY PRODUCTS TO 2019

    $1,195.00

  70. Overview

    $35.00

  71. ORAL DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars) 2004 - 2024

    $60.00

  72. Oral Controlled-Release Formulations: Overview (1 of 2)

    $35.00

  73. Oral Controlled-Release Formulations: Overview (2 of 2)

    $35.00

  74. CONTROLLED-RELEASE ORAL DRUG DELIVERY PRODUCT DEMAND BY TYPE & BY RELEASE (million dollars) 2004 - 2024

    $60.00

  75. CONTROLLED-RELEASE ORAL DRUG DELIVERY PRODUCT DEMAND BY THERAPEUTIC CLASS (million dollars) 2004 - 2024

    $60.00

  76. Oral Controlled-Release Formulations: Film-Coated (1 of 3)

    $35.00

  77. Oral Controlled-Release Formulations: Film-Coated (2 of 3)

    $35.00

  78. Oral Controlled-Release Formulations: Film-Coated (3 of 3)

    $35.00

  79. FILM-COATED ORAL DRUG DELIVERY PRODUCT DEMAND (million dollars) 2004 - 2024

    $60.00

  80. Oral Controlled-Release Formulations: Diffusion Tablets (1 of 2)

    $35.00

  81. Oral Controlled-Release Formulations: Diffusion Tablets (2 of 2)

    $35.00

  82. DIFFUSION ORAL DRUG DELIVERY PRODUCT DEMAND (million dollars) 2004 - 2024

    $60.00

  83. Oral Controlled-Release Formulations: Reservoir Technology

    $35.00

  84. RESERVOIR ORAL DRUG DELIVERY PRODUCT DEMAND (million dollars) 2004 - 2024

    $60.00

  85. Chewable Tablet Formulations

    $35.00

  86. CHEWABLE TABLET PRODUCT DEMAND BY THERAPEUTIC CLASS (million dollars) 2004 - 2024

    $60.00

  87. Orally Disintegrating Tablets (1 of 2)

    $35.00

  88. Orally Disintegrating Tablets (2 of 2)

    $35.00

  89. ORALLY DISINTEGRATING TABLET DEMAND BY THERAPEUTIC CLASS (million dollars) 2004 - 2024

    $60.00

  90. Oral Nanoparticulate Formulations (1 of 3)

    $35.00

  91. Oral Nanoparticulate Formulations (2 of 3)

    $35.00

  92. Oral Nanoparticulate Formulations (3 of 3)

    $35.00

  93. ORAL NANOPARTICULATE DRUG DELIVERY PRODUCT DEMAND BY THERAPEUTIC CLASS (million dollars) 2004 - 2024

    $60.00

  94. Oral Transmucosal Formulations (1 of 2)

    $35.00

  95. Oral Transmucosal Formulations (2 of 2)

    $35.00

  96. TRANSMUCOSAL DRUG DELIVERY PRODUCT DEMAND BY THERAPEUTIC CLASS (million dollars) 2004 - 2024

    $60.00

  97. PARENTERAL DRUG DELIVERY PRODUCTS: DRUG DELIVERY PRODUCTS TO 2019

    $1,910.00

  98. Overview

    $35.00

  99. PARENTERAL DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars) 2004 - 2024

    $60.00

  100. Therapeutic Monoclonal Antibodies: Overview

    $35.00

  101. THERAPEUTIC MONOCLONAL ANTIBODY DEMAND BY THERAPEUTIC CLASS (million dollars) 2004 - 2024

    $60.00

  102. Therapeutic Monoclonal Antibodies: Technology (1 of 2)

    $35.00

  103. Therapeutic Monoclonal Antibodies: Technology (2 of 2)

    $35.00

  104. Therapeutic Monoclonal Antibodies: Products (1 of 4)

    $35.00

  105. Therapeutic Monoclonal Antibodies: Products (2 of 4)

    $35.00

  106. Therapeutic Monoclonal Antibodies: Products (3 of 4)

    $35.00

  107. Therapeutic Monoclonal Antibodies: Products (4 of 4)

    $35.00

  108. Other Therapeutic Monoclonal Antibodies (1 of 3)

    $35.00

  109. Other Therapeutic Monoclonal Antibodies (2 of 3)

    $35.00

  110. Other Therapeutic Monoclonal Antibodies (3 of 3)

    $35.00

  111. New Therapeutic Monoclonal Antibody Products (1 of 4)

    $35.00

  112. New Therapeutic Monoclonal Antibody Products (2 of 4)

    $35.00

  113. New Therapeutic Monoclonal Antibody Products (3 of 4)

    $35.00

  114. New Therapeutic Monoclonal Antibody Products (4 of 4)

    $35.00

  115. Developmental Therapeutic Monoclonal Antibodies (1 of 2)

    $35.00

  116. Developmental Therapeutic Monoclonal Antibodies (2 of 2)

    $35.00

  117. ENCAPSULATED PARENTERAL PRODUCT DEMAND BY TYPE & THERAPEUTIC CLASS (million dollars) 2004 - 2024

    $60.00

  118. Encapsulated Parenteral Products: Polymer-Protected Formulations

    $35.00

  119. PEG-Based Polymer-Protected Parenteral Therapies (1 of 4)

    $35.00

  120. PEG-Based Polymer-Protected Parenteral Therapies (2 of 4)

    $35.00

  121. PEG-Based Polymer-Protected Parenteral Therapies (3 of 4)

    $35.00

  122. PEG-Based Polymer-Protected Parenteral Therapies (4 of 4)

    $35.00

  123. Other Polymer-Protected Parenteral Therapies

    $35.00

  124. Polymer-Protected Parenteral Formulations: Developmental Activities

    $35.00

  125. Encapsulated Parenteral Products: Liposomes

    $35.00

  126. Liposome Drug Delivery: Marketed Products (1 of 3)

    $35.00

  127. Liposome Drug Delivery: Marketed Products (2 of 3)

    $35.00

  128. Liposome Drug Delivery: Marketed Products (3 of 3)

    $35.00

  129. Liposome Drug Delivery: Developmental Activities

    $35.00

  130. Parenteral Drug Delivery: Infusion Products

    $35.00

  131. INFUSION PRODUCT DEMAND BY TYPE (million dollars) 2004 - 2024

    $60.00

  132. Infusion Products: IV Administration Sets (1 of 2)

    $35.00

  133. Infusion Products: IV Administration Sets (2 of 2)

    $35.00

  134. Infusion Products: Premixed IV Solutions

    $35.00

  135. Infusion Pumps (1 of 2)

    $35.00

  136. Infusion Pumps (2 of 2)

    $35.00

  137. Other Infusion Products (1 of 2)

    $35.00

  138. Other Infusion Products (2 of 2)

    $35.00

  139. PARENTERAL DEVICE DEMAND BY TYPE (million dollars) 2004 - 2024

    $60.00

  140. Prefillable Syringes: Injectors (1 of 3)

    $35.00

  141. Prefillable Syringes: Injectors (2 of 3)

    $35.00

  142. Prefillable Syringes: Injectors (3 of 3)

    $35.00

  143. Prefillable Syringes: Cartridge Systems (1 of 3)

    $35.00

  144. Prefillable Syringes: Cartridge Systems (2 of 3)

    $35.00

  145. Prefillable Syringes: Cartridge Systems (3 of 3)

    $35.00

  146. Hypodermic Syringes

    $35.00

  147. IV Catheters

    $35.00

  148. Other Parenteral Devices

    $35.00

  149. OTHER DRUG DELIVERY PRODUCTS: DRUG DELIVERY PRODUCTS TO 2019

    $1,415.00

  150. Overview

    $35.00

  151. OTHER DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars) 2004 - 2024

    $60.00

  152. Inhalation Drug Delivery Products: Overview

    $35.00

  153. INHALATION DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars) 2004 - 2024

    $60.00

  154. Inhalation Drug Delivery Products: Dry Powder Formulations (1 of 2)

    $35.00

  155. Inhalation Drug Delivery Products: Dry Powder Formulations (2 of 2)

    $35.00

  156. DRY POWDER INHALER DEMAND (million dollars) 2004 - 2024

    $60.00

  157. Inhalation Drug Delivery Products: Metered Dose Formulations (1 of 3)

    $35.00

  158. Inhalation Drug Delivery Products: Metered Dose Formulations (2 of 3)

    $35.00

  159. Inhalation Drug Delivery Products: Metered Dose Formulations (3 of 3)

    $35.00

  160. METERED DOSE INHALER DEMAND (million dollars) 2004 - 2024

    $60.00

  161. Transdermal Drug Delivery Products: Overview

    $35.00

  162. TRANSDERMAL DRUG DELIVERY PRODUCT DEMAND BY THERAPEUTIC CLASS (million dollars) 2004 - 2024

    $60.00

  163. Transdermal Drug Delivery Technologies

    $35.00

  164. Transdermal Drug Delivery Products: Central Nervous System Agents (1 of 4)

    $35.00

  165. Transdermal Drug Delivery Products: Central Nervous System Agents (2 of 4)

    $35.00

  166. Transdermal Drug Delivery Products: Central Nervous System Agents (3 of 4)

    $35.00

  167. Transdermal Drug Delivery Products: Central Nervous System Agents (4 of 4)

    $35.00

  168. Transdermal Drug Delivery Products: Hormones & Related Agents (1 of 2)

    $35.00

  169. Transdermal Drug Delivery Products: Hormones & Related Agents (2 of 2)

    $35.00

  170. Transdermal Drug Delivery Products: Cardiovascular Agents

    $35.00

  171. Other Transdermal Patches

    $35.00

  172. IMPLANTABLE DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars) 2004 - 2024

    $60.00

  173. Implantable Drug Delivery: Drug Inserts (1 of 2)

    $35.00

  174. Implantable Drug Delivery: Drug Inserts (2 of 2)

    $35.00

  175. DRUG INSERT DEMAND BY THERAPEUTIC CLASS (million dollars) 2004 - 2024

    $60.00

  176. Implantable Drug Delivery: Drug-Eluting Stents (1 of 2)

    $35.00

  177. Implantable Drug Delivery: Drug-Eluting Stents (2 of 2)

    $35.00

  178. DRUG-ELUTING STENT DEMAND 2004 - 2024

    $60.00

  179. Other Implantable Drug Delivery Products (1 of 4)

    $35.00

  180. Other Implantable Drug Delivery Products (2 of 4)

    $35.00

  181. Other Implantable Drug Delivery Products (3 of 4)

    $35.00

  182. Other Implantable Drug Delivery Products (4 of 4)

    $35.00

  183. OTHER IMPLANTABLE DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars) 2004 - 2024

    $60.00

  184. APPLICATIONS: DRUG DELIVERY PRODUCTS TO 2019

    $1,800.00

  185. Overview

    $35.00

  186. DRUG DELIVERY PRODUCT DEMAND BY THERAPEUTIC CLASS (million dollars) 2004 - 2024

    $60.00

  187. CENTRAL NERVOUS SYSTEM DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars) 2004 - 2024

    $60.00

  188. Central Nervous System Agents: Controlled-Release Formulations

    $35.00

  189. Central Nervous System Agents: Other Oral Drug Delivery Products

    $35.00

  190. Central Nervous System Agents: Transdermal Formulations (1 of 2)

    $35.00

  191. Central Nervous System Agents: Transdermal Formulations (2 of 2)

    $35.00

  192. Central Nervous System Agents: Monoclonal Antibodies & Polymer Encapsulated Therapies (1 of 2)

    $35.00

  193. Central Nervous System Agents: Monoclonal Antibodies & Polymer Encapsulated Therapies (2 of 2)

    $35.00

  194. Central Nervous System Agents: Liposomes & Other Drug Delivery Products

    $35.00

  195. HORMONE & RELATED DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars) 2004 - 2024

    $60.00

  196. Hormones & Related Agents: Anticancer Monoclonal Antibodies (1 of 4)

    $35.00

  197. Hormones & Related Agents: Anticancer Monoclonal Antibodies (2 of 4)

    $35.00

  198. Hormones & Related Agents: Anticancer Monoclonal Antibodies (3 of 4)

    $35.00

  199. Hormones & Related Agents: Anticancer Monoclonal Antibodies (4 of 4)

    $35.00

  200. Hormones & Related Agents: Encapsulated Polymers

    $35.00

  201. Hormones & Related Agents: Liposomes (1 of 2)

    $35.00

  202. Hormones & Related Agents: Liposomes (2 of 2)

    $35.00

  203. Hormones & Related Agents: Insulin Pen Injectors

    $35.00

  204. Hormones & Related Agents: Controlled-Release & Other Oral Drug Delivery Products

    $35.00

  205. Hormones & Related Agents: Transdermal Hormones & Related Agents

    $35.00

  206. Hormones & Related Agents: Other Drug Delivery Products

    $35.00

  207. RESPIRATORY DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars) 2004 - 2024

    $60.00

  208. Respiratory Agents: Dry Powder Inhalers (1 of 2)

    $35.00

  209. Respiratory Agents: Dry Powder Inhalers (2 of 2)

    $35.00

  210. Respiratory Agents: Metered Dose Inhalers (1 of 2)

    $35.00

  211. Respiratory Agents: Metered Dose Inhalers (2 of 2)

    $35.00

  212. Respiratory Agents: Monoclonal Antibodies

    $35.00

  213. Anti-Infective Agents: Drug Delivery Products

    $35.00

  214. ANTI-INFECTIVE DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars) 2004 - 2024

    $60.00

  215. Cardiovascular Agents: Drug Delivery Products

    $35.00

  216. CARDIOVASCULAR DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars) 2004 - 2024

    $60.00

  217. Cardiovascular Agents: Controlled-Release Formulations

    $35.00

  218. Cardiovascular Agents: Monoclonal Antibodies

    $35.00

  219. Cardiovascular Agents: Drug-Eluting Stents & Transdermal Patches (1 of 2)

    $35.00

  220. Cardiovascular Agents: Drug-Eluting Stents & Transdermal Patches (2 of 2)

    $35.00

  221. Gastrointestinal Agents: Drug Delivery Products (1 of 2)

    $35.00

  222. Gastrointestinal Agents: Drug Delivery Products (2 of 2)

    $35.00

  223. GASTROINTESTINAL DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars) 2004 - 2024

    $60.00

  224. Nutritional Agents: Drug Delivery Products

    $35.00

  225. NUTRITIONAL PREPARATION DELIVERY PRODUCT DEMAND BY TYPE (million dollars) 2004 - 2024

    $60.00

  226. Other Pharmaceuticals: Drug Delivery Products (1 of 3)

    $35.00

  227. Other Pharmaceuticals: Drug Delivery Products (2 of 3)

    $35.00

  228. Other Pharmaceuticals: Drug Delivery Products (3 of 3)

    $35.00

  229. OTHER APPLICATION DRUG DELIVERY PRODUCT DEMAND BY TYPE (million dollars) 2004 - 2024

    $60.00

  230. INDUSTRY STRUCTURE: DRUG DELIVERY PRODUCTS TO 2019

    $640.00

  231. General

    $35.00

  232. US DRUG DELIVERY PRODUCT SALES BY COMPANY, 2014 (million dollars)

    $60.00

  233. Market Share: Dosage Formulations

    $35.00

  234. DRUG DELIVERY FORMULATIONS, US MARKET SHARE BY LEADING COMPANIES, 2014 (percent)

    $60.00

  235. Market Share: Administration Devices

    $35.00

  236. DRUG DELIVERY DEVICES, US MARKET SHARE BY LEADING COMPANIES, 2014 (percent)

    $60.00

  237. Competitive Strategies

    $35.00

  238. Mergers & Acquisitions

    $35.00

  239. SELECTED ACQUISITIONS & DIVESTITURES

    $60.00

  240. Licensing & Related Agreements

    $35.00

  241. SELECTED COOPERATIVE AGREEMENTS (1 of 2)

    $60.00

  242. SELECTED COOPERATIVE AGREEMENTS (2 of 2)

    $60.00

  243. Marketing & Distribution

    $35.00

  244. Manufacturing

    $35.00

  245. COMPANY PROFILES: DRUG DELIVERY PRODUCTS TO 2019

    $2,380.00

  246. Company Profiles Methodology

    $35.00

  247. Abbott Laboratories

    $35.00

  248. AbbVie Incorporated

    $35.00

  249. Adare Pharmaceuticals (Aptalis Pharmaceutical) (1 of 2)

    $35.00

  250. Adare Pharmaceuticals (Aptalis Pharmaceutical) (2 of 2)

    $35.00

  251. Allergan plc (Forest Laboratories) (Actavis) (Aptalis Pharma) (1 of 3)

    $35.00

  252. Allergan plc (Forest Laboratories) (Actavis) (Aptalis Pharma) (2 of 3)

    $35.00

  253. Allergan plc (Forest Laboratories) (Actavis) (Aptalis Pharma) (3 of 3)

    $35.00

  254. Amgen Incorporated (1 of 2)

    $35.00

  255. Amgen Incorporated (2 of 2)

    $35.00

  256. AptarGroup Incorporated

    $35.00

  257. AstraZeneca plc (MedImmune) (1 of 2)

    $35.00

  258. AstraZeneca plc (MedImmune) (2 of 2)

    $35.00

  259. Baxter International (1 of 2)

    $35.00

  260. Baxter International (2 of 2)

    $35.00

  261. Becton, Dickinson, and Company (CareFusion) (1 of 5)

    $35.00

  262. Becton, Dickinson, and Company (CareFusion) (2 of 5)

    $35.00

  263. Becton, Dickinson, and Company (CareFusion) (3 of 5)

    $35.00

  264. Becton, Dickinson, and Company (CareFusion) (4 of 5)

    $35.00

  265. Becton, Dickinson, and Company (CareFusion) (5 of 5)

    $35.00

  266. Boehringer Ingelheim

    $35.00

  267. Braun (B.) Melsungen (1 of 2)

    $35.00

  268. Braun (B.) Melsungen (2 of 2)

    $35.00

  269. Bristol-Myers Squibb Company (1 of 2)

    $35.00

  270. Bristol-Myers Squibb Company (2 of 2)

    $35.00

  271. Evonik Industries

    $35.00

  272. Gerresheimer AG (1 of 2)

    $35.00

  273. Gerresheimer AG (2 of 2)

    $35.00

  274. Gilead Sciences

    $35.00

  275. GlaxoSmithKline plc (1 of 3)

    $35.00

  276. GlaxoSmithKline plc (2 of 3)

    $35.00

  277. GlaxoSmithKline plc (3 of 3)

    $35.00

  278. Johnson & Johnson (Janssen) (Animas) (1 of 3)

    $35.00

  279. Johnson & Johnson (Janssen) (Animas) (2 of 3)

    $35.00

  280. Johnson & Johnson (Janssen) (Animas) (3 of 3)

    $35.00

  281. Lilly (Eli) and Company (ImClone) (1 of 3)

    $35.00

  282. Lilly (Eli) and Company (ImClone) (2 of 3)

    $35.00

  283. Lilly (Eli) and Company (ImClone) (3 of 3)

    $35.00

  284. Merck & Company (1 of 3)

    $35.00

  285. Merck & Company (2 of 3)

    $35.00

  286. Merck & Company (3 of 3)

    $35.00

  287. Nitto Denko

    $35.00

  288. Novartis AG (1 of 4)

    $35.00

  289. Novartis AG (2 of 4)

    $35.00

  290. Novartis AG (3 of 4)

    $35.00

  291. Novartis AG (4 of 4)

    $35.00

  292. Novo Nordisk

    $35.00

  293. Pfizer Incorporated (Hospira) (1 of 5)

    $35.00

  294. Pfizer Incorporated (Hospira) (2 of 5)

    $35.00

  295. Pfizer Incorporated (Hospira) (3 of 5)

    $35.00

  296. Pfizer Incorporated (Hospira) (4 of 5)

    $35.00

  297. Pfizer Incorporated (Hospira) (5 of 5)

    $35.00

  298. Roche Holding (Genentech) (1 of 3)

    $35.00

  299. Roche Holding (Genentech) (2 of 3)

    $35.00

  300. Roche Holding (Genentech) (3 of 3)

    $35.00

  301. Sanofi (Genzyme) (Regeneron) (1 of 3)

    $35.00

  302. Sanofi (Genzyme) (Regeneron) (2 of 3)

    $35.00

  303. Sanofi (Genzyme) (Regeneron) (3 of 3)

    $35.00

  304. Teva Pharmaceutical Industries (1 of 3)

    $35.00

  305. Teva Pharmaceutical Industries (2 of 3)

    $35.00

  306. Teva Pharmaceutical Industries (3 of 3)

    $35.00

  307. 3M Company (1 of 2)

    $35.00

  308. 3M Company (2 of 2)

    $35.00

  309. Unilife Corporation (1 of 2)

    $35.00

  310. Unilife Corporation (2 of 2)

    $35.00

  311. Vetter Pharma International

    $35.00

  312. West Pharmaceutical Services

    $35.00

  313. Additional Companies in the Drug Delivery Product Market

    $35.00

Add Selections For Purchase

Back to Top